DEFINITIVE PROXY STATEMENT

Company

Outlook Therapeutics, Inc.

Filed

August 17, 2018

Period of Report

September 21, 2018

Accession Number

0001144204-18-045240

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →